Health Care & Life Sciences » Pharmaceuticals | Arbutus Biopharma Corp.

Arbutus Biopharma Corp.

Arbutus Biopharma Corp.
Stock Exchange NASDAQ Stock Market
EPS
 $1.32
Market Cap
 $127.91 M
Shares Outstanding
 56.85 M
Public Float
 33.5 M

Profile

Address
8900 Glenlyon Parkway
Burnaby British Columbia V5J 5J8
Canada
Employees -
Website http://www.arbutusbio.com
Updated 07/08/2019
Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada. .

Financials

View All
Created with Highcharts 5.0.14Arbutus Biopharma Corp.Net Income. Fiscal year is January-December. All values USD Thousands.14 06414 06438 83738 83761 12161 121384 164384 16484 41384 41357 06057 0602013201420152016201720180100k200k300k400k500k
Created with Highcharts 5.0.14Arbutus Biopharma Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.15 46415 46414 95314 95324 87324 8731 4911 49110 70010 7005 9455 94520132014201520162017201805k10k15k20k25k30k

Mark J. Murray
President, Chief Executive Officer & Director
William T. Symonds
Executive Director & Chief Development Officer
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.